A Kodak moment for the books: the former film giant flipped to pharma in a move aimed to rejuvenate the company after nearly two decades of hardship. Several reports state that Kodak branched out to offset the large-scale loss of its film business – punctuated by a bankruptcy in 2012 after the concept of the digital camera that it invented rendered many of its product offerings obsolete.
Initial talks of Kodak’s new active pharmaceutical ingredients (APIs) division, branded “Kodak Pharmaceuticals,” began as early as a few months ago according to Kodak CEO Jim Continenza. He says the move shouldn’t be all that surprising. Read More
In a special interview, Tuesday morning on the Tennessee Star Report with Michael Patrick Leahy – broadcast on Nashville’s Talk Radio 98.3 and 1510 WLAC weekdays from 5:00 a.m. to 8:00 a.m. – host Michael Patrick Leahy welcomed U.S. Republican Sen. Marsha Blackburn of Tennessee to the newsmakers line. Read More
by Molly Prince Democratic Sen. Elizabeth Warren introduced legislation on Tuesday that would establish a government-run pharmaceutical manufacturer to effectively compete with the private market. The Affordable Drug Manufacturing Act seeks to address the increasing prices of prescription drugs by injecting competition into the marketplace, consequently lowering the cost… Read More